Eton Pharmaceuticals, Inc. IPO Research Information

Eton Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Eton Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Eton Pharmaceuticals, Inc.	ETON - NASDAQ	$6.00-$6.00	$6.00	$0.00	3.6 million	11/14/2018
Underwriter(s): National Securities
Co-Manager(s):
Industry: Health Care
Filing(s): Terms Changed 2018-11-06 Filed 2018-08-10

Eton Pharmaceuticals, Inc. Quote & Chart - Click for current quote - ETON

About Eton Pharmaceuticals, Inc. (adapted from Eton Pharmaceuticals, Inc. prospectus):
Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ETON" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.